Gsa Capital Partners LLP Beyond Air, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.42 - $11.39 $30,147 - $46,277	4,063 Added 9.29%	47,791 $356,000
Q2 2022 Aug 09, 2022	SELL	$4.96 - $7.83 $49,208 - $77,681	-9,921 Reduced 18.49%	43,728 $293,000
Q1 2022 May 11, 2022	SELL	$6.33 - $9.53 $71,206 - $107,202	-11,249 Reduced 17.33%	53,649 $358,000
Q4 2021 Feb 14, 2022	SELL	$8.44 - $15.61 $319,496 - $590,916	-37,855 Reduced 36.84%	64,898 $613,000
Q3 2021 Nov 12, 2021	SELL	$5.9 - $12.54 $32,674 - $69,446	-5,538 Reduced 5.11%	102,753 $1.14 Million
Q2 2021 Aug 05, 2021	BUY	$4.72 - $7.15 $294,400 - $445,966	62,373 Added 135.84%	108,291 $702,000
Q1 2021 May 10, 2021	BUY	$5.13 - $7.24 $59,985 - $84,657	11,693 Added 34.17%	45,918 $253,000
Q4 2020 Feb 03, 2021	BUY	$5.18 - $6.03 $177,285 - $206,376	34,225 New	34,225 $180,000

11.1M

54.4K

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $17M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.